|
|
 |
|
 |
Research Studies Project QUEST: Organizational Factors and Quality of Chronic Disease Care A Multicenter, Multinational, Randomized, Double-Blind, Parallel-Group Study of the Effects of a Study Drug and Beclomethasone on Lens Opacification in Adult Subjects with Moderate to Severe Persistent Asthma A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of a Study Drug in Patients with Perennial Allergic Rhinitis A Two-Staged Randomized, Open-Label, Parallel Group, Phase III, Multicenter, Seven-Month Study to Assess the Efficacy and Safety of a Study Drug Administered Either as Fixed or as an Adjustable Regimen Versus a Fixed Regimen of Advair™ in Subjects 12 Years of Age and Older with Asthma A 52-Week, Randomized, Double-Blind, Single-Dummy, Parallel-Group, Multicenter Phase III Study Comparing the Long-Term Safety of a Study Drug X 4 Actuations Twice Daily to the Same Study Drug X 2 Actuations Twice Daily and Budesonide X 4 Actuations Twice Daily in Adult and Adolescent Subjects with Asthma A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of a Study Drug in Patients with Seasonal Allergic Rhinitis – A Pilot Study During the Fall Season A 24-Week, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Study Drug (250 mcg. or 500 mcg.) Daily in Patients with Asthma Long-Term Safety Study of a Study Nasal Spray A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial with a Study Solution for Inhalation in Mild to Moderate Asthma Patients A Multicenter, Double-Blind, Randomized Study Investigating the Clinical Effect of a Study Drug on Allergic Rhinitis in Patients with Seasonal Allergic Rhinitis and Chronic Asthma A Randomized, Double-Blind, Placebo-Controlled Trial of a Study Nasal Spray at a Dosage of One Spray per Nostril Twice Daily in Patients with Seasonal Allergic Rhinitis A 12-Week, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study of a Study Drug Administered Once Daily in Children and Adolescents 6 to 15 Years of Age with Asthma (SPROUT) Phase II, Randomized, Blinded, Placebo-Controlled, Multiple-Dose, Dose-Finding Study to Evaluate the Safety and Clinical Activity of a Study Drug in Patients with Ragweed-Induced Seasonal Allergic Rhinitis A Multicenter, Double-Blind, Randomized, Parallel Study Comparing the Efficacy and Safety of Investigational Doses of a Study Drug and Placebo in Subjects with Perennial Allergic Rhinitis A 12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial of a Combination Study Drug Versus its Mono-Products in Children (>6 years of age) and Adults with Asthma A Stratified, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Safety and Efficacy of a Powder Combination of a Study Drug and an Inhaled Study Drug in Symptomatic Pediatric Subjects (4-11 Years) with Asthma A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Efficacy and Safety of a Powder Combination of a Study Drug and an Inhaled Study Drug in Symptomatic Adolescent and Adult Subjects with Asthma that is not Controlled on Short-Acting Beta2 Agonists Alone A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 16-Week Comparison of Asthma Control in Adolescents and Adults Receiving an Approved Combination Inhaler for Four Weeks, Then Switching to One of Four Therapies A Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study of Four Months Duration per Subject to Evaluate the Safety and Efficacy of a Study Drug in Adolescent and Adult Subjects with Persistent Stable Asthma A Multicenter, Open-Label, Randomized, Parallel Group Study to Assess the Long-Term Safety Performance of a Medication Currently Approved for Treating SAR Compared to a Medication Currently Approved for Long-Term Treatment of Asthma in Subjects with Asthma A Multicenter, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of a Medication, Currently Approved for Treating SAR, in Subjects with Mild to Moderate Persistent Asthma A Phase IIIa, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study on the Efficacy and Safety of a Study Drug in Chronic Idiopathic Urticaria Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Efficacy and Safety of a Study Drug in Subjects Hospitalized with Worsening Congestive Heart Failure A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Pilot Study Evaluating the Efficacy and Safety of a Study Drug in Patients with Decompensated Chronic Heart Failure Registry of Cardiac Resynchronization Therapy-US (RESTORE-US) A Double-Blind, Randomized, Multicenter, Dose-Ranging Trial of a Study Drug Compared with Clopidogrel in Subjects Undergoing Percutaneous Coronary Intervention (JUMBO-TIMI 26) Efficacy and Safety of a New Oral Direct Thrombin Inhibitor Compared with Dose Adjusted Warfarin (Coumadin) in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V) Pravastatin or Atorvastatin Evaluation and Infectious Therapy (PROVE IT) Pain Free Rx II (Does Pacing Fast VT Reduce Shock Rx?) A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Study Drug-Device Combination in the Treatment of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures Anna Westin House Residential Outcomes Study The Cost of Bulimia Nervosa The Effect of an Oral Contraceptive on Bone Mineral Density in Pediatric Subjects with Anorexia Nervosa: A Double-Blind, Placebo-Controlled Study Assessing the Management of Eating Disorders in Family Practice Eating Disorders Stage of Change: Reliability and Validity of a New Measure A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New Formulation of a Study Drug in the Acute Treatment of Migraine Minnesota Heart Survey Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance of Congestive Heart Failure Improving Utilization of Ischemic Stroke Research Vaccine Safety Data Link Project A National Center for Value Purchasing Methods (1758-03) Weight Management, Physical Activity, Less Disability in Rheumatoid and Osteoarthritis Impact of Secure Messaging on the COMPASS Program Lyme025—A Cohort Study: Safety Reporting on Participants Receiving Lyme Vaccine (Post Marketing Surveillance) Colon Cancer Survivors: Medication and Risk of Recurrence Cancer Surveillance in HMO Administrative Data Women’s Perception of Cardiovascular Disease Risk Purchaser/Provider Evaluation: Hospital Quality Data, TN Which Patients Want to Examine Their Medical Record? Healthy Young Workers Project: A Demonstration Project to Implement and Evaluate Promising Policy Change Initiatives with 18-24 Year-Olds A Randomized, Double-Blind, Controlled Dose Finding Study of a Study Drug for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy A Randomized, Prospective, Pilot Study of Adherence Monitoring and Intervention in HIV-Infected Patients Receiving a Kaletra-Based HRRT Regimen A Phase III, Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of a Study Drug in Combination with an Optimized Background Regimen, Versus Optimized Background Regimen Alone, in Patients with Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors) An Open-Label Study Assessing the Safety and Tolerability of Chronic Dosing with a Study Drug in HIV Positive Subjects Who Have Failed Therapy with a Fusion Inhibitor Containing Regimen A Multicenter, Double-Blind, Placebo-Controlled, Randomized Study of the Safety of a Study Drug in the Treatment of Patients with Type 2 Diabetes Mellitus Outcomes of Dual Therapy with Rosiglitazone and Metformin Compared to Sulfonylurea and Metformin for Treatment of Type 2 Diabetes: A Non-Randomized, Parallel-Groups Study Based on Retrospective Medical Record Review Long-Term Effects of Insulin plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients with Type 2 Diabetes: A Comparison of Pre-Meal Insulin Lispro Mixtures to Once-Daily Insulin Glargine Field Evaluation of User Performance for a Blood Glucose Monitoring System A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of a Study Drug 9 mg. and 30 mg. in Patients with Diabetic Polyneuropathy A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Study Drug Added to Insulin in Patients with Adequately Controlled Type 2 Diabetes Mellitus A Study Drug versus Placebo in the Treatment of Patients with Painful Diabetic Neuropathy The Efficacy and Safety of a Study Drug for the Treatment of Type 2 Diabetes A Multicenter, International, Randomized Study to Evaluate the Effects of Insulin Glargine Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High-Risk People with Impaired Fasting Glucose, Impaired Glucose Tolerance or Early Type 2 Diabetes Mellitus A Multicenter, Double-Blind Study to Evaluate the Effect of Pre-Treatment with a Daily Dose of Study Drug on the PRN Efficacy of the Study Drug in Men with Erectile Dysfunction and Type 2 Diabetes Worksite Diabetes Management: Partnering for Success Intensive Care Unit Glucose Control Study Admission Glucose ICU Study Prevalence of Peripheral Neuropathy in Type 1 and Type 2 Diabetes: Coexistence with Other Diabetic Microvascular Complications Partners in Advancing Care and Education Solutions The Effect a Study Drug on Albuminuria in Patients with Type 2 Diabetes A Study Drug Treatment of Peripheral Neuropathy in Patients with Diabetes: A Phase III Pivotal Trial A Study Drug for Symptomatic Peripheral Neuropathy in Patients with Diabetes Evaluation of Interstitial Fluid Glucose Monitoring with the TheraSense Continuous Monitoring System An Open-Label Extension Study of Protocol 2993-115 to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of a Study Drug Given Two Times a Day to Subjects Treated with Metformin and a Sulfonylurea Morning Long-Acting Insulin Versus Intermediate-Acting Insulin Twice Daily as Basal Insulin in a Multiple Daily Injection Regimen with Rapid-Acting Insulin in Adolescents with Type 1 Diabetes Mellitus: An Active-Controlled, Open, Randomized, Gender-Stratified, Two-Arm, Parallel-Group Study Efficacy and Safety of a New Insulin Compared to Placebo in Patients with Type 2 Diabetes Mellitus Following Diabetes Education Driving Safety and Diabetes The ANSWER Program: The Norditropin National Registry Program Basal/Bolus Therapy with Rapid-Acting Insulin Versus Short-Acting Insulin, or Rapid-Acting Insulin in Combination with Intermediate-Acting Insulin: Open-Label, Randomized, Parallel-Group, Multicenter Study in Children and Adolescents with Type 1 Diabetes A Study Drug in Type 2 Hypertriglyceridemic Diabetic Subjects: A 26-Week Double-Blind, Multicenter, Randomized, Parallel, Active-Controlled Study to Investigate Safety and Efficacy Central Obesity and Elevated Albumin Excretion in Type 1 Diabetes Diabetes Coaching at the Worksite Collaborative Care Model for Diabetes in the School Setting Smoking Cessation in Adults with Type 2 Diabetes A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Compared to Metformin or Glyburide/Glibenclamide in Patients with Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus (<2 Years) Concentration Control Trial of Norditropin® SimpleXx™ in Children with Growth Hormone Deficiency: A Two-Year, Open-Label, Randomized, Multicenter Trial Comparison of Two Study Drugs in Subjects with Type 2 Diabetes Mellitus and Dyslipidemia Action to Control Cardiovascular Risk in Diabetes (ACCORD) The DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Genetic Studies of Diabetic Complications in Epidemiology of Diabetes Interventions and Complications A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Two Study Drugs in Hypertensive Patients with Type 2 Diabetes Mellitus Evaluation of the Dose-Response Relationship of a Study Drug on Fasting and Postprandial Blood Glucose and Tolerability in Patients with Type 2 Diabetes Field Evaluation of a New Blood Glucose Monitoring System: Accuracy, Lay-User Acceptability and Precision Program Evaluation: Measuring the Effectiveness of Intensive Insulin Therapy through Multiple Daily Injections and a Continuous Subcutaneous Insulin Infusion Diabetes Management Program (AIM) A Prospective, Multinational, Multicenter, Double-blind, Randomized, Active-Controlled Trial to Compare the Effects of a Study Drug to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension (ACCOMPLISH) A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New Formulation of a Study Drug in the Acute Treatment of Migraine The Safety and Efficacy of an Extended Release Study Drug in Migraine Prophylaxis: A Double-Blind, Placebo-Controlled Study in Adolescents Carotid Occlusion Surgery Study A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of an Oral Medication for a Single, Moderate or Severe Headache in Adults Diagnosed with Migrainous Disorder A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial to Evaluate Early Efficacy and Tolerability of a Study Nasal Spray in the Acute Treatment of Adult Subjects With Migraine Essure™ System United States Post-Approval Study for Newly Trained Physicians Efficacy and Safety of a Study Drug Compared with Placebo in Women with Symptoms of Mixed Urinary Incontinence: Protocol Helicobacter Pylori Infection and Hyperemesis Gracidarum in Women from Somalia A Model of Patient and Nursing Administration Outcomes
Effectiveness of a Machine Guarding Intervention Work Wise: A School-Based Agricultural Intervention A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Study Drug Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects An Open-Label, Randomized, Phase III Study of Intermittent Oral Study Drug in Combination with Intravenous Study Drug Versus Bolus and Continuous Infusion Leucovorin with Intravenous Oxaliplatin as First-Line Treatment for Patients with Metastatic Colorectal Cancer and Accompanying Sample Repository Research Project An Open-Label, Randomized, Phase III Study of Intermittent Oral Study Drug in Combination with an Intravenous Study Drug Versus Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who Have Undergone Surgery for Colon Carcinoma, AJCC/UICC Stage III (Dukes Stage C) and Roche Sample Repository Research Project (RSR) for Use in Conjunction with this Study The Effects of Zolendronic Acid (Zometra™) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer Predictors of Lymphedema Following Breast Cancer Surgery A Study to Assess Symptom Burden in Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and a Study Drug A Phase I Dose-Escalation Study of Thrice-Weekly Study Drug in Combination with Trastuzumab in Subjects with HER-2/neu Positive Metastatic Breast Cancer A Multicenter, Open-Label Trial to Evaluate the Efficacy and Safety of a Study Drug of Relapsed or Refractory Low-Grade or Follicular Transformed B-Cell Non-Hodgkin's Lymphoma A Randomized, Open-Label, Multicenter Study of Primary Prophylaxis with a Study Drug Versus Secondary Prophylaxis as an Adjunct to Chemotherapy in Elderly Subjects (65 Years Old) with Cancer Dietary Intake in Women with Breast Cancer: Study 1: Comparison to National Data Sets; Study 2: Predictors to Adherence to a Low-Fat Diet Intervention A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women with Clinical Stage T1 or T2 Breast Cancer A Randomized Trial of Axillary Node Dissection in Women With Clinical Stage T1 or T2 N0M Breast Cancer Who Have a Positive Sentinel Node Breast Cancer Risk Factors and Diagnostic Mammogram Sensitivity Among Women Diagnosed with Breast Cancer in their Forties Breast Cancer Adjuvant Educational Program (BCAEP): A Randomized Clinical Trial of a Computer-Based Learning Tool to Aid in Decision-Making Concerning Adjuvant Therapy for Early Breast Cancer A Multicenter Clinical Trial to Determine the Efficacy of a Dietary Fat Reduction Program Provided in Addition to Systemic Adjuvant Therapy in the Management of Patients with Primary Invasive Breast Cancer Sunbelt Melanoma Trial (SMT): A Multicenter Trial of Adjuvant Interferon Alfa-2b for Melanoma Patients with Early Lymph Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy A Prospective Study to Compare Side Effects and Functional Status by Treatment Type for Early Stage Prostate Cancer An Expanded Access Clinical Program with a Study Drug for Patients with Advanced Non-Small Cell Lung Cancer Study Drug in an Alternative Dose (ILIAD Trial): Treatment of Patients with Metastatic Renal Cell Carcinoma with Low-Dose Proleukin A Pilot Study of a Combination of Mitoxantrone, Estramustine, Weekly Paclitaxel (Taxol) and Hydrocortisone (METH) for the Treatment of Hormone-Resistant Prostate Cancer An Open-Label, Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and Study Drug Intraoperative Subareolar Injection of Technetium-99 for Breast Sentinel Lymph Node Identification
Shoulder Prosthesis Study Double-Blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of a Study Drug on the Rate of Healing in Distal Radius Fractures Rapid Diagnosis of Malaria with Antigen Capture Compared to Smear and PCR in Symptomatic Patients in Minnesota Human Growth Hormone in Children with Growth Failure Associated with Insulin-like Growth Factor Deficiency: A 12-Month, Open-Label, Randomized, Parallel Group Study Synagis Outcomes Registry
Computer Aided Detection of Mammograms Computer Aided Detection of Full Field Digital Mammography Cases
A Phase III Multicenter Study of the Safety and Efficacy of a Study Drug in Moderate to Severely Active Psoriatic Arthritis Subjects with Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy and a Continuation Trial A Randomized, Multi-Factorial, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of a Study Drug in Combination with Methotrexate in Patients with Rheumatoid Arthritis Randomized, Multicenter, Parallel-Group Study to Determine if Knowledge of Baseline Vertebral Fracture Prevalence (as Determined by Hologic IVA) and Bone Turnover Marker Levels Improves Persistence with Study Drug. Daily Therapy in Subjects Receiving Chronic Glucocorticoid Therapy Comparison of the Effects of Two Individual Study Drugs on Lumbar Spine Bone Mineral Density in Glucocorteroid-Induced Osteoporosis A Phase III, Randomized, Multicenter Study Comparing the Safety and Efficacy of a Study Drug Versus Allopurinol in Subjects with Gout BioMarkers for Anti-TNF Response in Rheumatoid Arthritis A Study of the Agreement between the Standard and Modified ACR Improvement Criteria in Rheumatoid Arthritis Subjects Receiving Study Drug After Having an Unsatisfactory Response to Disease-Modifying Anti-Rheumatic Drug Therapy (DMARDS) or Study Drug Outcome Measurements Evaluation with Treatment Accuracy of Lateral X-ray Absorptiometry to Detect Vertebral Compression Fracture Deformities Compared to Standard Radiography, and Impact of their Detection on Therapy to Prevent Osteoporotic Fracture Osteoporosis Education and Screening in the Community: Effect on Health Care Behavior with Respect to Preventing Osteoporosis in Employed Populations SONORA: Study of New-Onset Rheumatoid Arthritis Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) Can Patients Self-Select Themselves for Bone Densitometry? Utility of the Osteoporosis Risk Assessment Instrument (ORAI) Mailed to Women Age 45 and Older Treatment of Early Rheumatoid Arthritis: Minocycline in Combination with Methotrexate Versus Methotrexate Alone Triple III: Comparison of Leflunomide Alone Versus Two Disease-Modifying Anti-Rheumatic Drug (DMARD) Combinations (Leflunomide-Hydroxychloroquine-Sulfasalazine or Methotrexate-Hydroxychloroquine-Sulfasalazine) in the Treatment of Rheumatoid Arthritis An International, Multicenter, Stratified, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 52-Week Gastrointestinal Clinical Safety Study to Demonstrate that a New COX II Inhibitor Reduces the Risk to Develop Complicated Ulcers as Compared to Naproxen (500mg. BID), in Rheumatoid Arthritis and Osteoarthritis Patients An Open-Label Study to Evaluate the Efficacy and Safety of a Study Drug Administered “On Demand” to Men of Various Populations with Erectile Dysfunction A Multicenter, Open Label, Flexible Dose Study to Investigate the Use Patterns of a Study Drug and the Ability of Investigators to Further Optimize Subject Satisfaction with that Study Drug Through Customized Instruction A Multicenter, Double-Blind, Pilot Study of Two Study Drugs in Subjects with Early Untreated Parkinson’s Disease A Multicenter, Family-Based Study of Genetic Determinants of Parkinson’s Disease A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of a Study Drug as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Levodopa/Carbidopa Therapy A Long-Term, Multicenter, Open-Label Safety Study with a Flexible-Dose Range of a Study Drug as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Levodopa/Carbidopa Therapy A Prospective, Randomized, Placebo-Controlled, Parallel-Group Study of the Continued Efficacy and Safety of Subcutaneous Injections of a Study Drug in the Treatment of "Off" Episodes in Patients with "On/Off" or "Wearing-Off" Effects Associated with Late-Stage Parkinson's Disease after Apomorphine Use for at least a Three-Month Duration Optimizing Therapeutic Outcome with Comtan in Parkinson’s Disease Patients Plasma Half-Life of Levodopa after Administration of Additional Carbidopa in PD Patients Already Treated with a Combination of Carbidopa/Levodopa and Entacapone A Comparative, Prospective, Randomized, Double-Masked, Parallel Group, Controlled Trial of a Study Therapy Versus Sham Control When Added to Standard Care in the Treatment of Diabetic Neuropathic Ulcers |
||
| ||||
